Back
Sarepta Therapeutics, Inc. Vs. Cava Group, Inc. Industry Stock Comparison
Sell
42
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.03
Seasonality Move:
10.38%
Sell
35
CAVA
Cava Group, Inc.
Last Price:
$56.91
Seasonality Move:
9.43%
Sell
42
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.04. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Cava Group, Inc. (CAVA)
is a Sell
Is Cava Group, Inc. a Buy, Sell or Hold?
-
The current Cava Group, Inc. [CAVA] share price is $56.91. The Score for CAVA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
CAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
CAVA Stock Price Chart
What is Cava Group, Inc.'s stock price today?
-
The Cava Group, Inc. share price today is $56.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 51.11 | Buy |
| Chaikin Money Flow: | 1527880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.4 - 22.24) | Buy |
| Bollinger Bands (100): | (17.55 - 22.19) | Buy |
CAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 62.8 | Buy |
| Chaikin Money Flow: | 3401656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.25 - 54.49) | Buy |
| Bollinger Bands (100): | (51.1 - 72.04) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.48 | Sell |
| 20-day SMA: | 21.06 | Sell |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 32.06 | Sell |
| 8-day EMA: | 11.03 | Buy |
| 20-day EMA: | 5.4 | Buy |
| 50-day EMA: | 2.36 | Buy |
| 200-day EMA: | 0.62 | Buy |
CAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.7 | Buy |
| 20-day SMA: | 52.26 | Buy |
| 50-day SMA: | 54.21 | Buy |
| 200-day SMA: | 73.5 | Sell |
| 8-day EMA: | 54.22 | Buy |
| 20-day EMA: | 52.93 | Buy |
| 50-day EMA: | 54.94 | Buy |
| 200-day EMA: | 72.07 | Sell |
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.
Cava Group, Inc. Earnings Growth & CAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.05 per share.
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cava Group, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||